Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: Clinicopathologic analysis of 5 cases

Journal of Cutaneous Pathology

Volumn 23, Issue 1, 1996, Pages 30-36

  Calonje, Eduardo ^a   Fletcher, Christopher D M ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIBODY; CD34 ANTIGEN; DESMIN;

ABDOMINAL WALL; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; EOSINOPHIL; FEMALE; FIBROSARCOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; PATHOLOGY; SCALP; SPINDLE CELL; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD34; CELL DIFFERENTIATION; DERMATOFIBROSARCOMA; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0030028231     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb00774.x     Document Type: Article

References (27)

1. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962: 15: 717.
2. Fletcher CDM, Evans BJ, Macartney JC, Smith N, Wilson Jones E, McKee PH. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology 1985: 9: 921.
3. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol 1985: 9: 630.
4. Fletcher CDM, Theaker JM, Flanagan A, Krausz T. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathology 1988: 13: 631.
5. Frierson HF, Cooper PH. Myxoid variant of dermatofibrosarcoma protuberans. Am J Surg Pathol 1983: 7: 445.
6. Wrotnowski U, Cooper PH, Shmookler BM. Fibrosarcomatous change in dermatofibrosarconia protuberans. Am J Surg Pathol 1988: 12: 287.
7. Ding J, Hashimoto H, Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumours. Cancer 1989: 64: 721.
8. Connelly JH, Evans HL. Dermatofibrosarconia protuberans: a clinicopathological review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 1992: 16: 921.
9. Shmookler BM, Enzinger FM, Weiss SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 1989: 64: 2154.
10. Beham A, Fletcher CDM. Dermatofibrosarcoma protuberans with areas resembling giant cell fibroblastoma: report of two cases. Histopathology 1990: 17: 165.
11. Coyne J, Kafton SM, Craig RDP. Dermatofibrosarconia protuberans recurring as a giant cell fibroblastoma. Histopathology 1992: 21: 184.
12. Alguacil-Garcia A. Giant cell fibroblastoma recurring as dermatofibrosarcoma protuberans. Am J Surg Pathol 1991: 15: 798.
13. Banerjee SS, Harris M, Eyden BP, Hamid BNA. Granular cell variant of dermatofibrosarcoma protuberans. Histopathology 1990: 17: 375.
14. Ozello L, Hamels J. The histiocytic nature of dermatofibrosarcoma protuberans. Tissue culture and electron microscopic study. Am J Clin Pathol 1976: 65: 136.
15. Hashimoto K, Brownstein MH, Jakobiec FA. Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch Dermatol 1974: 110: 874.
16. Escalona-Zapata J, Fernandez EA, Escuin FL. The fibroblastic nature of dermatofibrosarcoma protuberans. A tissue culture and ultrastructural study. Virchows Arch [A] 1981: 391: 165.
17. Albini A, Krieg T, Schmoeckel C, Weber I, Mueller P. Dermatofibrosarcoma protuberans: altered collagen metabolism in cell culture. J Invest Dermatol 1985: 85: 381.
18. Alguacil-Garcia A, Unni KK, Goellner JR. Histogenesis of dermatofibrosarcoma protuberans: ultrastructural study. Am J Clin Pathol 1978: 69: 427.
19. Lautier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol 1990: 12: 25.
20. Aiba S, Tabala N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol 1992: 127: 79.
21. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed paraffin-embedded tissue. J Am Acad Dermatol 1993: 28: 613.
22. Brathwaite C, Suster S. Dermatofibrosarcoma protuberans. A critical reappraisal of the role of immunohistochemical stains for diagnosis. Appl Immunohistochem 1994: 2: 36.
23. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells and perifollicullar cells in formalin-fixed normal skin and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's Sarcoma. Arch Dermatol 1991: 127: 523.
24. Van de Rijn M, Rouse RV. CD34. A Review. Appl Immunohistochem 1994: 2: 71.
25. Schurch W, Seemaver TA, Cabbiani G. Myofibroblast. In: Sternberg SS (ed). Histology for pathologists. New York: Raven Press, 1992: 109.
26. Smith KJ, Skelton HG, Barrett TL, Lupton GP, Graham JH. Cutaneous myofibroma. Mod Pathol 1989: 2: 603.
27. Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer 1981: 48: 1807.